EZZ Life Science Holdings Ltd
ASX:EZZ
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.46
4.96
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
EZZ Life Science Holdings Ltd
Common Stock
EZZ Life Science Holdings Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Common Stock
AU$6.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
827%
|
CAGR 10-Years
N/A
|
|
|
Anteotech Ltd
ASX:ADO
|
Common Stock
AU$99.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Common Stock
AU$36.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Common Stock
AU$101.5m
|
CAGR 3-Years
28%
|
CAGR 5-Years
705%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Common Stock
AU$3.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Common Stock
AU$119.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
EZZ Life Science Holdings Ltd
Glance View
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.
See Also
What is EZZ Life Science Holdings Ltd's Common Stock?
Common Stock
6.9m
AUD
Based on the financial report for Jun 30, 2024, EZZ Life Science Holdings Ltd's Common Stock amounts to 6.9m AUD.
What is EZZ Life Science Holdings Ltd's Common Stock growth rate?
Common Stock CAGR 5Y
827%
Over the last year, the Common Stock growth was 14%. The average annual Common Stock growth rates for EZZ Life Science Holdings Ltd have been 7% over the past three years , 827% over the past five years .
You don't have any saved screeners yet
